Immunitybio inc IBRX.US Value Analysis
IBRX Value Score
3
24
15
- AI analysis rates IBRX with a higher value score of 4.
- It is mainly due to stable revenue growth, along with adequate safety shown in the balance sheet.
- Over the past 3 months, IBRX has maintained a consecutive value rating of 4.0, slightly higher than the rating of 3.0 over the past 3 years, indicating higher growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, IBRX has a higher value rating.
IBRX Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/06 (Weekly Update)
IBRX Financial Forecast
Unit : USD
Update to 2025/5/13 (Quarterly Update)
IBRX Earnings Table
Unit : USD
QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
---|---|---|---|---|---|---|---|
Current | -0.15 | 21.1% | -42.3% | 7.55M | 5,333.1% | -21.5% | -1,404% |
2024Q2 | -0.14 | 26.3% | -22.2% | 6.11M | 7,346.3% | -32.7% | -12,852.3% |
2024Q1 | -0.2 | 28.6% | 17.6% | 1.05M | 2,453.7% | -58.5% | -335,272.5% |
2023Q4 | -0.2 | 25.9% | 25% | 40K | -88.9% | 100% | -167,907.9% |
2023Q3 | -0.19 | 29.6% | 5.6% | 139K | 90.4% | 595% | -116,563.4% |
Update to 2025/5/14 (Quarterly Update)
IBRX Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
IBRX Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
The Backtest Result of IBRX from 2015/08 till Now
- -78.58%
- Cumulative Return
- -14.63%
- Annual Return
- 59.01%
- Volatility
- -0.25
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from August, 2015 to May, 2025. (Total Trades: 2)
IBRX | Sector | US Overall Market | |
---|---|---|---|
Wining Rate | - | 45% | 54% |
Avg Return | -48.7% | 63.1% | 75% |
Avg Profit | - | 197% | 167.9% |
Avg Loss | -48.7% | -44.8% | -34.5% |
Avg Risk-Reward Ratio | - | 440% | 486.6% |
Update to 2025/5/14 (Daily Update)